Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)
暂无分享,去创建一个
J. Erickson | D. M. van der Heijde | E. Lespessailles | J. Birt | V. Chandran | R. Burgos-Vargas | P. Helliwell | R. Fleischmann | G. Gallo | H. Kameda | C. Shuler | A. T. Sprabery | S. Rathmann